GO:0004983 neuropeptide Y receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004983 (neuropeptide Y receptor activity) is a molecular function defined as combining with neuropeptide Y to initiate a change in cell activity.
• The NPY receptor family comprises Y1, Y2, Y4, Y5 and y6 subtypes, which differ in pharmacology, tissue distribution and downstream signaling.
• NPY receptor activation regulates diverse processes including mitogenesis, vasoconstriction, spinal itch circuitry, the Bezold-Jarisch reflex and bone metastasis.
• Structural studies of the Y2 receptor have revealed the basis for NPY and peptide YY recognition and receptor activation.
• Dysregulated NPY receptor signaling is implicated in cancer progression, cardiovascular reflexes and sensory neuron disorders.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of NPY receptor function in these contexts.
Description
Neuropeptide Y (NPY) is one of the most abundant neuropeptides in the mammalian nervous system, and its actions are mediated by a family of G-protein-coupled receptors that together define the Gene Ontology molecular function neuropeptide Y receptor activity (GO:0004983). This term describes the binding of NPY to a receptor and the subsequent initiation of a change in cell activity, a definition that encompasses the Y1, Y2, Y4, Y5 and y6 receptor subtypes. Because these receptors couple to diverse intracellular effectors, the same ligand can elicit distinct physiological outcomes depending on which receptor subtype is expressed. For researchers, GO:0004983 provides a precise annotation target for experiments that measure ligand-receptor engagement and downstream signaling. Pharmacological and molecular studies have shown that NPY receptor interactions can regulate mitogenic activity, and that receptor subtype selectivity is a key determinant of biological output. Structural work on the Y2 receptor has further clarified how NPY and peptide YY bind and stabilize active receptor conformations, offering a template for understanding subtype-specific signaling. Beyond basic neurobiology, NPY receptor activity is increasingly recognized in disease mechanisms. Hypoxia-activated NPY/Y5 receptor/RhoA signaling has been linked to chromosomal instability and bone metastasis in Ewing sarcoma, while NPY neurons in the spinal cord mediate opioid-induced itch by disinhibiting GRP-GRPR microcircuits. NPY also acts as a direct vasoconstrictor and facilitates P2X1 receptor-dependent vasoconstriction in human small abdominal arteries, and vagal sensory neurons mediate the Bezold-Jarisch reflex and syncope through NPY-related pathways. These findings make GO:0004983 a high-value annotation for both mechanistic and translational research.
neuropeptide Y receptor activity At A Glance
| GO ID | GO:0004983 |
|---|---|
| GO term | neuropeptide Y receptor activity |
| Ontology | molecular_function |
| Synonym | none listed in QuickGO |
| Definition | Combining with neuropeptide Y to initiate a change in cell activity. |
| Major function | Binding of neuropeptide Y to Y1, Y2, Y4, Y5 and y6 receptors to initiate intracellular signaling. |
| Receptor family | G-protein-coupled receptors with subtype-specific pharmacology and tissue distribution. |
| Key ligands | Neuropeptide Y, with related peptides peptide YY and pancreatic polypeptide showing subtype-dependent cross-reactivity. |
| Representative processes | Mitogenesis, vasoconstriction, spinal itch transmission, Bezold-Jarisch reflex, bone metastasis. |
What Is GO:0004983?
In our own words, GO:0004983 (neuropeptide Y receptor activity) is the molecular function of a receptor protein that selectively binds neuropeptide Y and, upon binding, triggers a change in the activity of the cell. This function is characteristic of the NPY receptor family, which includes Y1, Y2, Y4, Y5 and y6 subtypes, and it is distinct from the activity of receptors for related peptides such as peptide YY or pancreatic polypeptide, although cross-reactivity can occur depending on subtype. The definition emphasizes both the binding event and the functional consequence, meaning that assays for this term should capture ligand recognition and downstream signaling rather than binding alone.
Why Is neuropeptide Y receptor activity Important in Cell Biology?
GO:0004983 is important because NPY receptor activity sits at the intersection of neurobiology, cardiovascular physiology and cancer biology. The same molecular function can drive mitogenic signaling in one context and modulate vasoconstriction or sensory reflexes in another, depending on receptor subtype and cellular environment. This pleiotropy makes precise annotation essential for interpreting experiments that use NPY receptor ligands or genetic models, and it explains why dysregulated NPY receptor activity has been linked to diseases as diverse as Ewing sarcoma, opioid-induced itch and syncope.
• Defines the molecular function of a major neuropeptide receptor family with five known subtypes.
• Regulates mitogenic activity through receptor-receptor interactions, relevant to cell proliferation studies.
• Contributes to hypoxia-driven chromosomal instability and bone metastasis in Ewing sarcoma via Y5 receptor/RhoA signaling.
• Mediates opioid-induced itch through NPY neurons that disinhibit GRP-GRPR microcircuits in the spinal cord.
• Acts as a direct vasoconstrictor and facilitates P2X1 receptor-dependent vasoconstriction in human small abdominal arteries.
• Participates in the Bezold-Jarisch reflex and syncope through vagal sensory neuron pathways.
• Provides a structural template for subtype-selective drug design based on Y2 receptor-NPY/PYY complexes.
• Serves as a benchmark annotation for GPCR signaling studies in neuroscience and oncology.
Molecular Mechanism of neuropeptide Y receptor activity
Ligand recognition and binding
In simple terms: The receptor first grabs neuropeptide Y, like a lock accepting a key.
Neuropeptide Y receptor activity begins with the selective binding of NPY to the receptor's orthosteric pocket. Pharmacological characterization of NPY receptor subtypes has established that Y1, Y2, Y4, Y5 and y6 receptors differ in their affinity for NPY and related peptides, which underlies subtype-specific physiological responses. Structural analysis of the Y2 receptor in complex with NPY and peptide YY has provided a molecular view of how the ligand engages the receptor and stabilizes an active conformation.
Receptor activation and conformational change
In simple terms: Once NPY is bound, the receptor changes shape to pass the signal inside the cell.
Binding of NPY induces conformational rearrangements in the receptor that propagate from the ligand-binding pocket to the cytoplasmic face, enabling coupling to heterotrimeric G proteins. The Y2 receptor structures reported by Kang et al. illustrate how NPY and peptide YY binding leads to distinct active states, providing a basis for understanding subtype-selective signaling. This activation step is the core of the GO:0004983 definition, which requires not only binding but also initiation of a change in cell activity.
Downstream signaling and effector coupling
In simple terms: The activated receptor talks to G proteins and other proteins to change what the cell does.
Activated NPY receptors couple to intracellular effectors that modulate diverse cellular processes. In Ewing sarcoma, hypoxia-activated NPY/Y5 receptor signaling engages RhoA to trigger chromosomal instability and bone metastasis, demonstrating that downstream effector choice is context-dependent. In human small abdominal arteries, NPY acts as a direct vasoconstrictor and facilitates P2X1 receptor-dependent vasoconstriction, showing that NPY receptor activity can intersect with purinergic signaling.
Receptor-receptor interactions and mitogenic signaling
In simple terms: NPY receptors can cooperate with other receptors to promote cell growth.
Neuropeptide Y receptor interactions regulate its mitogenic activity, indicating that the functional output of GO:0004983 can be shaped by crosstalk with other membrane receptors. This has implications for interpreting proliferation assays and for designing experiments that isolate NPY receptor-specific effects from those of co-expressed receptors.
Neural circuit and reflex functions
In simple terms: In the nervous system, NPY receptor activity helps control itch and blood pressure reflexes.
NPY neurons mediate opioid-induced itch by disinhibiting GRP-GRPR microcircuits in the spinal cord, a process that depends on NPY receptor activity in specific neuronal populations. Vagal sensory neurons mediate the Bezold-Jarisch reflex and induce syncope, and NPY-related signaling in these neurons contributes to cardiovascular reflex control. These examples show that GO:0004983 operates in both local circuits and systemic reflexes.
Key Genes Involved in GO:0004983 neuropeptide Y receptor activity
The following genes and proteins are central to neuropeptide Y receptor activity and its downstream biology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NPY | Encodes neuropeptide Y, the endogenous ligand for GO:0004983 | Ligand source for receptor activation assays and circuit mapping |
| NPY1R | Y1 receptor subtype mediating NPY signaling | Subtype-specific pharmacology and mitogenic signaling studies |
| NPY2R | Y2 receptor subtype with structural data for NPY/PYY binding | Template for understanding receptor activation and drug design |
| NPY4R | Y4 receptor subtype with distinct peptide selectivity | Subtype comparison and tissue-specific function studies |
| NPY5R | Y5 receptor subtype linked to hypoxia-driven metastasis | Cancer biology and RhoA signaling research |
| NPY6R | y6 receptor subtype (species-dependent expression) | Comparative pharmacology and receptor evolution studies |
| PYY | Peptide YY, a related ligand that can activate NPY receptors | Ligand selectivity and structural studies |
| PPY | Pancreatic polypeptide, a related peptide with subtype-dependent activity | Receptor subtype selectivity profiling |
| RHOA | Downstream effector of Y5 receptor signaling | Mechanistic studies of chromosomal instability and metastasis |
| P2RX1 | P2X1 receptor that interacts with NPY signaling in arteries | Vascular reactivity and co-signaling experiments |
| GRP | Gastrin-releasing peptide in spinal itch microcircuits | Circuit-level studies of NPY neuron disinhibition |
| GRPR | GRP receptor in spinal itch circuits | Target for itch pathway dissection |
| GNAI1 | Gi alpha subunit potentially coupling to NPY receptors | GPCR signaling assays and effector mapping |
| GNAQ | Gq alpha subunit potentially coupling to NPY receptors | Subtype-specific signaling studies |
| ARRB1 | Beta-arrestin 1 involved in GPCR desensitization | Receptor regulation and internalization studies |
| ARRB2 | Beta-arrestin 2 involved in GPCR desensitization | Receptor regulation and signaling bias studies |
| SRC | Non-receptor tyrosine kinase downstream of GPCRs | Mitogenic signaling and proliferation assays |
How Is neuropeptide Y receptor activity Regulated?
Neuropeptide Y receptor activity is regulated at multiple levels, including ligand availability, receptor subtype expression and receptor-receptor interactions. Pharmacological studies have shown that different NPY receptor subtypes exhibit distinct binding profiles and can be selectively engaged by natural peptides and synthetic antagonists, which provides a mechanism for context-dependent regulation. Receptor-receptor interactions can modulate mitogenic activity, indicating that the functional output of GO:0004983 is not determined by ligand binding alone. In disease settings, hypoxia can activate NPY/Y5 receptor/RhoA signaling, illustrating that environmental cues regulate this molecular function. Additionally, NPY neurons in the spinal cord can be engaged by opioid signaling to disinhibit GRP-GRPR microcircuits, showing that neural circuit activity regulates NPY receptor-dependent outputs.
neuropeptide Y receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NPY5R | Ewing sarcoma bone metastasis and chromosomal instability | NPY5R knockout or point-mutation in sarcoma cell lines |
| NPY | Opioid-induced itch and spinal circuit disinhibition | NPY neuron-specific knockout in mouse spinal cord |
| NPY1R | Mitogenic signaling and cell proliferation | NPY1R overexpression or knockout in proliferation assays |
| NPY2R | Receptor activation and peptide recognition | Knock-in of tagged NPY2R for structural and signaling studies |
| P2RX1 | Vascular reactivity and vasoconstriction | P2RX1/NPY receptor co-expression models in arterial smooth muscle |
Neuropeptide Y receptor activity in cancer
Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma, directly linking GO:0004983 to tumor progression. Neuropeptide Y receptor interactions also regulate mitogenic activity, suggesting that receptor crosstalk can influence proliferation in cancer cells. These findings support the investigation of NPY receptor subtypes as potential therapeutic targets in sarcoma and other malignancies.
Neuropeptide Y receptor activity in sensory and itch circuits
NPY neurons mediate opioid-induced itch by disinhibiting GRP-GRPR microcircuits in the spinal cord, a process that depends on NPY receptor activity in specific neuronal populations. This positions GO:0004983 as a key annotation for studies of itch transmission and opioid side effects. Understanding how NPY receptor signaling modulates these circuits may inform strategies to separate analgesia from itch.
Neuropeptide Y receptor activity in cardiovascular reflexes
Vagal sensory neurons mediate the Bezold-Jarisch reflex and induce syncope, and NPY-related signaling contributes to these cardiovascular responses. In human small abdominal arteries, NPY acts as a direct vasoconstrictor and facilitates P2X1 receptor-dependent vasoconstriction, linking GO:0004983 to vascular tone regulation. These roles highlight the importance of NPY receptor activity in blood pressure control and reflex syncope.
From neuropeptide Y receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NPY5R reduce hypoxia-driven metastasis? | NPY5R knockout in Ewing sarcoma cell lines and xenografts |
| How does NPY receptor subtype selectivity affect signaling? | Point mutations in NPY1R or NPY2R ligand-binding pocket |
| Can tagged NPY2R reveal receptor trafficking? | Knock-in of fluorescent or affinity tags at the endogenous NPY2R locus |
| Does NPY overexpression alter spinal itch circuits? | NPY overexpression in spinal cord neurons |
| Which receptors mediate vasoconstriction in human arteries? | Receptor-specific knockout or knockdown in vascular smooth muscle cells |
| How does NPY receptor activity modulate reflex syncope? | Vagal sensory neuron-specific knockout of NPY receptors in mice |
How to Study the neuropeptide Y receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioligand binding | Ligand-receptor affinity and subtype selectivity | Characterizing NPY receptor pharmacology |
| Cryo-EM / crystallography | Receptor structure and ligand-bound conformations | Understanding Y2 receptor activation by NPY/PYY |
| CRISPR knockout | Loss-of-function effects on receptor-mediated processes | Testing NPY5R role in metastasis |
| Conditional knockout in mice | Tissue-specific receptor function in vivo | Dissecting NPY neuron role in itch circuits |
| Calcium imaging | GPCR-mediated calcium signaling | Measuring NPY receptor activation in neurons |
| RhoA activation assay | Downstream effector activation | Linking Y5 receptor to chromosomal instability |
| Vascular reactivity assay | Vasoconstriction and P2X1 facilitation | Studying NPY effects in human arteries |
| Vagal reflex recording | Bezold-Jarisch reflex and syncope | Evaluating NPY receptor contribution to cardiovascular reflexes |
Pharmacological and binding assays
Radioligand binding and competition assays using subtype-selective agonists and antagonists are standard methods to measure neuropeptide Y receptor activity and to distinguish Y1, Y2, Y4, Y5 and y6 subtypes. These assays provide direct evidence for the binding component of GO:0004983 and are often combined with functional readouts to confirm receptor activation.
Structural biology and receptor modeling
Cryo-EM and X-ray crystallography of NPY receptors in complex with NPY or peptide YY reveal the molecular basis of ligand recognition and activation. Such structures can guide mutagenesis experiments and subtype-selective drug design, and they provide a structural framework for interpreting functional data on GO:0004983.
Genetic and circuit-level approaches
Knockout, knockdown and conditional genetic models in mice and cell lines allow researchers to test the causal role of specific NPY receptor subtypes in processes such as itch, vasoconstriction and metastasis. Circuit-level techniques, including neuronal tracing and optogenetics, can map how NPY receptor activity influences spinal and vagal pathways.
Signaling and effector assays
Measurements of downstream effectors such as RhoA activation, calcium mobilization and GPCR-coupled second messengers can quantify the functional consequences of NPY receptor engagement. These assays are essential for linking GO:0004983 to cellular outcomes like proliferation, migration and vascular contraction.
How CRISPR Can Be Used to Study GO:0004983 neuropeptide Y receptor activity
Knockout
CRISPR knockout of NPY receptor genes such as NPY5R or NPY1R can eliminate receptor activity and reveal its contribution to proliferation, metastasis or vascular responses. Knockout models are particularly useful for testing whether a specific subtype is required for a given phenotype, as demonstrated in Ewing sarcoma studies where Y5 receptor loss affects RhoA signaling and bone metastasis.
Point Mutation
Point mutations in the ligand-binding pocket or intracellular loops of NPY receptors can dissect the molecular determinants of ligand recognition and G-protein coupling. Such mutations are informed by structural data on the Y2 receptor and can be used to test subtype-specific signaling hypotheses.
Knock-in
Knock-in of fluorescent or affinity tags at endogenous NPY receptor loci enables real-time tracking of receptor expression, trafficking and localization in native cells. Tagged knock-in models can also facilitate proximity labeling and interactome studies to identify novel components of NPY receptor signaling.
Overexpression
Overexpression of NPY or specific NPY receptor subtypes can amplify signaling and reveal gain-of-function phenotypes in cell lines and animal models. For example, NPY overexpression in spinal neurons can be used to study circuit-level effects on itch transmission, while receptor overexpression can enhance mitogenic responses in proliferation assays.
How EDITGENE Supports neuropeptide Y receptor activity Research
Researchers studying neuropeptide Y receptor activity-related genes often need to determine whether a candidate gene is causally involved in a specific signaling or disease phenotype. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models that support such causal inference, from receptor knockout to tagged knock-in and overexpression.
Contact EDITGENE today to design your custom CRISPR model for neuropeptide Y receptor activity research.
Frequently Asked Questions About neuropeptide Y receptor activity
What is neuropeptide Y receptor activity?
Neuropeptide Y receptor activity (GO:0004983) is the molecular function of combining with neuropeptide Y to initiate a change in cell activity, mediated by Y1, Y2, Y4, Y5 and y6 receptor subtypes.
What genes are involved in neuropeptide Y receptor activity?
Key genes include NPY (the ligand), NPY1R, NPY2R, NPY4R, NPY5R and NPY6R (receptor subtypes), and downstream effectors such as RHOA.
Which receptors mediate neuropeptide Y signaling?
The NPY receptor family comprises Y1, Y2, Y4, Y5 and y6 subtypes, which differ in pharmacology, tissue distribution and downstream coupling.
How is neuropeptide Y receptor activity studied?
Common methods include radioligand binding, structural biology, CRISPR knockout, calcium imaging, RhoA activation assays and vascular reactivity assays.
What diseases are linked to neuropeptide Y receptor activity?
NPY receptor signaling has been linked to Ewing sarcoma bone metastasis, opioid-induced itch, vasoconstriction and the Bezold-Jarisch reflex.
What is the role of NPY5R in cancer?
Hypoxia-activated NPY/Y5 receptor/RhoA signaling triggers chromosomal instability and bone metastasis in Ewing sarcoma.
How do NPY neurons mediate itch?
NPY neurons mediate opioid-induced itch by disinhibiting GRP-GRPR microcircuits in the spinal cord.
What is the structural basis of NPY receptor activation?
Structures of the Y2 receptor bound to NPY and peptide YY reveal how ligand binding stabilizes active receptor conformations.
Does neuropeptide Y affect blood vessels?
Yes, NPY acts as a direct vasoconstrictor and facilitates P2X1 receptor-dependent vasoconstriction in human small abdominal arteries.
How can CRISPR help study neuropeptide Y receptor activity?
CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of receptor subtype function in disease and physiology.
Conclusion
GO:0004983 (neuropeptide Y receptor activity) defines a central molecular function that links the abundant neuropeptide NPY to diverse physiological and pathological outcomes through Y1, Y2, Y4, Y5 and y6 receptors. Structural and pharmacological studies have clarified how NPY and related peptides engage these receptors, while disease-focused work has connected receptor activity to cancer metastasis, itch circuits, vasoconstriction and cardiovascular reflexes. For researchers, precise annotation of GO:0004983 and the use of CRISPR-based models will be essential to dissect subtype-specific mechanisms and to translate these findings into therapeutic strategies. EDITGENE's knockout, point-mutation, knock-in, overexpression and screening services provide a practical route to generate such models.
References
- 1. Czarnecka M et al.. 2019. Neuropeptide Y receptor interactions regulate its mitogenic activity.. Neuropeptides 73:11-24 PMID: 30503694
- 2. Lu C et al.. 2022. Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma.. Nat Commun 13(1):2323 PMID: 35484119
- 3. Wan CP et al.. 1995. Neuropeptide Y receptor subtypes.. Life Sci 56(13):1055-64 PMID: 9001438
- 4. Zeng Q et al.. 2025. Neuropeptide Y neurons mediate opioid-induced itch by disinhibiting GRP-GRPR microcircuits in the spinal cord.. Nat Commun 16(1):7074 PMID: 40750771
- 5. Kang H et al.. 2023. Structural basis for Y2 receptor-mediated neuropeptide Y and peptide YY signaling.. Structure 31(1):44-57.e6 PMID: 36525977
- 6. Del Carmen Gonzalez-Montelongo M et al.. 2023. Neuropeptide Y: Direct vasoconstrictor and facilitatory effects on P2X1 receptor-dependent vasoconstriction in human small abdominal arteries.. Vascul Pharmacol 151:107192 PMID: 37419269
- 7. Lovelace JW et al.. 2023. Vagal sensory neurons mediate the Bezold-Jarisch reflex and induce syncope.. Nature 623(7986):387-396 PMID: 37914931
- 8. Balasubramaniam AA. 1997. Neuropeptide Y family of hormones: receptor subtypes and antagonists.. Peptides 18(3):445-57 PMID: 9145434
